Management and control of asthma as assessed by actual/best function and corticosteroid use 1980-1993/4

European Respiratory Journal

Volumn 12, Issue 4, 1998, Pages 859-864

  Connolly, C K ^a,b   Alcock, S M ^b   Prescott, R J ^c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b DARLINGTON MEMORIAL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Actual best function; Asthma; Best function; Inhaled corticosteroids; Oral corticosteroids; Therapeutic step

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM;

ADULT; ARTICLE; ASTHMA; CLINICAL PRACTICE; COHORT ANALYSIS; DISEASE CONTROL; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LONGITUDINAL STUDY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; STEROID THERAPY; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; ASTHMA; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROGNOSIS; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX;

EID: 0031722627     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.12040859     Document Type: Article

References (17)

1. British Thoracic Society, Research Unit of the Royal College of Physicians of London, King's Fund Centre, National Asthma Campaign. Guidelines for management of asthma in adults: I - chronic persistent asthma. BMJ 1990; 301: 651-654.
2. Sheffer AL, Chairman. International consensus report on diagnosis and management of asthma. Clin Exp Allergy 1992; 22: Suppl. 1.
3. Moran F, Bankier JDH, Boyd G. Disodium cromoglycate and the treatment of allergic bronchial asthma. Lancet 1968; ii: 137-139.
4. Cameron SJ, Cooper EJ, Crompton GK, Hoare MV, Grant IWB. Substitution of beclomethasone dipropionate aerosol for oral prednisolone in the treatment of chronic asthma. BMJ 1973; 4: 205-207.
5. Partridge MR. Delivering optimal care to the person with asthma, what are the key components and what do we mean by patient education. Eur Respir J 1995; 8: 298-305.
6. Connolly CK. Management of asthma in outpatients. J R Coll Phy Lon 1983; 17: 115-120.
7. Connolly CK. Age and the prescription of drugs for asthma. Br J Clin Pract 1984; 38: 45-48.
8. Connolly CK, Prescott RJ, Alcock SM, Gatnash AA. Actual over best function as an outcome measure for asthma. Respir Med 1994; 88: 453-459.
9. British Thoracic Society, et al. (Woodhead M. ed). Guidelines on the management of asthma. Thorax 1995; 52: Suppl. 1.
10. Connolly CK, Chan NS, Prescott RJ. The relationship between age and duration of asthma and the presence of persistent obstruction in asthma. Post Grad Med J 1988; 64: 422-425.
11. Connolly CK, Prescott RJ. Pulmonary function and drug regimens in asthmatics. Br J Clin Pract 1990; 44: 148-153.
12. Cotes JE. Lung Function, 4th Edn. Oxford, Blackwell Scientific Publications, 1979.
13. Bucknall CE. Definitions of severity and outcome measures. Respir Med 1996; 90: 447-452.
14. Alcock SM, Mamun M, Prescott RJ, Connolly CK. Symptoms and pulmonary function in asthma. Respir Med 1998; in press.
15. Connolly CK, Mamun M, Alcock SM, Prescott RJ. The Darlington and Northallerton prospective asthma study: best function predicts mortality in the first 10 years. Eur Respir J 1998; in press.
16. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994; 88: 373-381.
17. Haahtela T, Jarvenin M, Kava T, et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 1994; 331: 700-705.